Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
    Veterinary regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Glossaries
    • About this website
    • Data protection and privacy
    • FAQs
    • Contacts

COVID-19

All info here

QUICK LINKS

  • Latest updates
  • Vaccines
  • Treatments
  • Guidance for developers and companies
  • Highlights of the safety committee: December 2023
    PRAC highlights October 2021
    MEDICINES |COMMITTEES

    Highlights of the safety committee: December 2023

  • Highlights of the safety committee: December 2023
    PRAC highlights October 2021
    MEDICINES |COMMITTEES

    Highlights of the safety committee: December 2023

    At its monthly meeting, the PRAC recommended measures for medicines containing pseudoephedrine and agreed to request further evidence in the GLP-1 receptor agonists’ review.

  • COVID-19 public health emergency: lessons learned
    Image for news on Covid-19
    LESSONS LEARNED |COVID-19

    COVID-19 public health emergency: lessons learned

  • COVID-19 public health emergency: lessons learned
    Image for news on Covid-19
    LESSONS LEARNED |COVID-19

    COVID-19 public health emergency: lessons learned

    EMA and the Heads of Medicines Agencies review their response to COVID-19 and highlight key learnings in a joint report.

  • Call for patient representatives to join COMP
    Rare diseases |Patients

    Call for patient representatives to join COMP

  • Call for patient representatives to join COMP
    Rare diseases |Patients

    Call for patient representatives to join COMP

    The European Commission has launched a call for expressions of interest to represent patients’ organisations in EMA's Committee for Orphan Medicinal Products

  • Looking for scientific experts to work with PRAC
    Pharmacovigilance |Expert

    Looking for scientific experts to work with PRAC

  • Looking for scientific experts to work with PRAC
    Pharmacovigilance |Expert

    Looking for scientific experts to work with PRAC

    The European Commission is running a selection procedure to appoint six independent scientific experts to EMA’s safety committee

Search for medicines
Search for information on human, veterinary or herbal medicines.
What's new
Find all the latest news and updates published on this website in one place.
FAQs
Find answers to the most frequently asked questions we receive.

Latest news

  • List item
    01/12/2023 COVID-19

    EU medicines agencies reflect on lessons learned from COVID-19

    The European Medicines Regulatory Network (EMRN) has been at the forefront of the fight against COVID-19 with its crucial role in the evaluation and monitoring of medicines, including vaccines. A j oint report issued by the European Medicines Agency...

  • List item
    01/12/2023

    Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023

    PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine EMA’s safety committee, PRAC, has recommended new measures for medicines containing pseudoephedrine to minimise the risks of posterior...

  • List item
    20/11/2023

    Consumption of antimicrobials in animals reaches lowest level ever in Europe

    European countries have substantially reduced sales of veterinary antibiotics, which translates into a lower risk of bacteria becoming resistant in people and animals. Overall sales of veterinary antibiotics decreased by 53% between 2011 and 2022,...

  • List item
    10/11/2023

    Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 2023

    The Committee adopted by consensus positive opinions for variations requiring assessment concerning quality-related changes for: Equioxx Onsior Simparica Trio, Felisecto Plus, MiPet Easecto, Simparica, Stronghold Plus (worksharing procedure)...

  • List item
    10/11/2023

    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023

    Eight new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its November 2023 meeting. The CHMP adopted a positive opinion for Omjjara* (momelotinib), for the treatment of...

  • List item
    09/11/2023

    Getting ready for EMA’s website relaunch on 5 December 2023

    The European Medicines Agency (EMA) is relaunching its corporate website on Tuesday 5 December. From day one, EMA is giving its website a fresh look and feel. The website will also feature a new, simple medicines search, clearer navigation and a...

  • Load more news

Information for you

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of medicine development

Key content

  • List item

    Product emergency hotline

  • List item

    UK’s withdrawal from the EU

  • List item

    PRIME: Priority medicines

  • List item

    Pharmacovigilance (safety monitoring)

  • List item

    Data on medicines

  • List item

    Clinical data publication

  • List item

    Careers

Services & databases

  • List item

    Clinical Trials website

  • List item

    Account Management portal

  • List item

    eSubmission

  • List item

    EudraVigilance (human)

  • List item

    EudraVigilance Veterinary

  • List item

    Veterinary Medicines information website

  • List item

    Suspected adverse drug reactions database

  • List item

    Clinical data

  • List item

    SPOR data management services

  • List item

    Service Desk

  • List item

    IRIS platform

  • List item

    Public register of parallel distribution notices

  • List item

    European Vaccination Information Portal

How does EMA work?

  • List item

    What we do

  • List item

    Our role in authorisation of medicines

  • List item

    Who we are

  • List item

    Our scientific experts

  • List item

    How we work

  • List item

    What we publish

Product emergency hotline
outside working hours
  • About us
  • What we do
  • Careers
  • Committees
  • Regulatory network
  • Languages
  • Frequently asked questions
  • Glossaries
  • About this website
  • Privacy
  • Search tips
  • Access to documents
  • Contacts
  • Send a question
  • EMA Service desk (system support)

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

How to find us

Postal address and deliveries

Business hours and holidays

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
RSS feed Twitter YouTube LinkedIn
© 1995-2023 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag